106190 Stock Chart & Stats
₩10680.00
₩340.00(3.29%)
―
--
Day’s Range― - ―
52-Week Range₩9,540.00 - ₩25,000.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)43.65K
Market Cap
₩109.94B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)12.2
Beta0.02
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding10,633,173
10 Day Avg. Volume60,577
30 Day Avg. Volume43,654
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
106190 FAQ
What was High Tech Pharm. Co., Ltd.’s price range in the past 12 months?
High Tech Pharm. Co., Ltd. lowest stock price was ₩9540.00 and its highest was ₩25000.00 in the past 12 months.
What is High Tech Pharm. Co., Ltd.’s market cap?
High Tech Pharm. Co., Ltd.’s market cap is ₩109.94B.
When is High Tech Pharm. Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were High Tech Pharm. Co., Ltd.’s earnings last quarter?
High Tech Pharm. Co., Ltd. released its earnings results on May 15, 2026. The company reported -₩25.113 earnings per share for the quarter, missing the consensus estimate of N/A by -₩25.113.
Is High Tech Pharm. Co., Ltd. overvalued?
According to Wall Street analysts High Tech Pharm. Co., Ltd.’s price is currently Undervalued.
Does High Tech Pharm. Co., Ltd. pay dividends?
High Tech Pharm. Co., Ltd. does not currently pay dividends.
What is High Tech Pharm. Co., Ltd.’s EPS estimate?
High Tech Pharm. Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does High Tech Pharm. Co., Ltd. have?
High Tech Pharm. Co., Ltd. has 10,633,173 shares outstanding.
What happened to High Tech Pharm. Co., Ltd.’s price movement after its last earnings report?
High Tech Pharm. Co., Ltd. reported an EPS of -₩25.113 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.672%.
Which hedge fund is a major shareholder of High Tech Pharm. Co., Ltd.?
Currently, no hedge funds are holding shares in KR:106190
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
JEIL PHARMA HOLDINGS INC.
―
Cell Biotech Co., Ltd
―
CMG Pharmaceutical Co., Ltd.
―
Genexine, Inc.
―
Keeps Biopharma Inc.
―